Company: DERM
Filing Date: 2025-03-24
Form Type: 8-K
Source: 0001104659-25-026878
Chunk: 0

Company: Journey Medical Corp
Filing Date: 2025-03-24
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01      Other Events.  

On March 24, 2025, Journey Medical Corporation
(“ Journey Medical” or the “Company”) announced the launch of and the first prescriptions filled
for Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for
the treatment of inflammatory lesions of rosacea in adults. A copy of the launch press release issued by Journey Medical is attached hereto
as Exhibit 99.1 and incorporated herein by reference.